Analysis of data from the European Scleroderma Trials and Research (EUSTAR) cohort has initially identified six subsets of systemic sclerosis (SSc), as opposed to the binary classification of limited and diffuse cutaneous SSc. We now move closer to a more actionable SSc classification for improved clinical care and trial design.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
Arthritis Research & Therapy Open Access 14 March 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Johnson, S. R., Feldman, B. M. & Hawker, G. A. Classification criteria for systemic sclerosis subsets. J. Rheumatol 34, 1855–1863 (2007).
van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum. 65, 2737–2747 (2013).
Sobanski, V. et al. Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis. Arthritis Rheumatol. https://doi.org/10.1002/art.40906 (2019).
Carrier, M.-E. et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND): study protocol. J. Scleroderma Relat. Disord. 3, 91–97 (2018).
Soowamber, M. L. et al. Online obituaries are a reliable and valid source of mortality data. J. Clin. Epidemiol. 79, 167–168 (2016).
Deo, R. C. Machine learning in medicine. Circulation 132, 1920–1930 (2015).
Johnson, S., Hinchcliff, M. & Asano, Y. Controversies: molecular versus clinical systemic sclerosis classification. J. Scleroderma Relat. Disord. 1, 277–285 (2016).
Hinchcliff, M. et al. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J. Invest. Dermatol. 133, 1979–1989 (2013).
Lofgren, S. et al. Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight 1, e89073 (2016).
Acknowledgements
The authors thank S. R. Johnson for her input. The work of M.H. is supported by a grant from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR073270. M.H. maintains an adjunct professor role at the Northwestern University Feinberg School of Medicine, Department of Medicine, Division of Rheumatology. The work of J.M.M. is supported by a grant from the National Institutes of Health, National Library of Medicine (NLM) R21LM012615.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.H. receives NIH research support for genomic SSc research. J.M.M. declares no competing interests.
Rights and permissions
About this article
Cite this article
Hinchcliff, M., Mahoney, J.M. Towards a new classification of systemic sclerosis. Nat Rev Rheumatol 15, 456–457 (2019). https://doi.org/10.1038/s41584-019-0257-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-019-0257-z
This article is cited by
-
Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies
Clinical Reviews in Allergy & Immunology (2021)
-
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
Arthritis Research & Therapy (2020)